281 related articles for article (PubMed ID: 32451073)
1. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2102-2110.e1. PubMed ID: 28947198
[TBL] [Abstract][Full Text] [Related]
4. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
[TBL] [Abstract][Full Text] [Related]
5. Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2016 Aug; 102(2):407-15. PubMed ID: 27177840
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Eur J Cardiothorac Surg; 2022 Aug; 62(3):. PubMed ID: 35293580
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm.
Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
Jpn J Clin Oncol; 2020 Oct; 50(11):1306-1312. PubMed ID: 32901276
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
Sakurai H; Goto Y; Yoh K; Takamochi K; Shukuya T; Hishida T; Tsuboi M; Yoshida K; Ohde Y; Okumura S; Taguri M; Kunitoh H
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38598462
[TBL] [Abstract][Full Text] [Related]
10. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852
[TBL] [Abstract][Full Text] [Related]
11. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219
[TBL] [Abstract][Full Text] [Related]
12. Oncological characteristics of epidermal growth factor receptor-mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance.
Hattori A; Matsunaga T; Fukui M; Tomita H; Takamochi K; Suzuki K
J Thorac Cardiovasc Surg; 2023 Nov; ():. PubMed ID: 37995863
[TBL] [Abstract][Full Text] [Related]
13. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
[TBL] [Abstract][Full Text] [Related]
14. Impact of a Ground-glass Opacity Component on c-Stage IA Lung Adenocarcinoma.
Li M; Xi J; Sui Q; Kuroda H; Hamanaka K; Bongiolatti S; Hong G; Zhan C; Feng M; Wang Q; Tan L
Semin Thorac Cardiovasc Surg; 2023 Winter; 35(4):783-795. PubMed ID: 35907612
[TBL] [Abstract][Full Text] [Related]
15. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Classification of Multiple Primary Lung Cancers Based on a Ground-Glass Opacity Component.
Hattori A; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2020 Feb; 109(2):420-427. PubMed ID: 31593656
[TBL] [Abstract][Full Text] [Related]
17. Differences in the prognostic implication of ground-glass opacity on CT according to pathological nodal status in lung cancers treated with lobectomy or pneumonectomy.
Park S; Lee SM; Choe J; Choi S; Kim S; Do KH; Seo JB
Eur Radiol; 2022 Jul; 32(7):4405-4413. PubMed ID: 35141781
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis.
Lee JH; Choi Y; Hong H; Kim YT; Goo JM; Kim H
Eur Radiol; 2024 Mar; 34(3):1905-1920. PubMed ID: 37650971
[TBL] [Abstract][Full Text] [Related]
19. Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.
Iwano S; Umakoshi H; Kamiya S; Yokoi K; Kawaguchi K; Fukui T; Naganawa S
Cancer Imaging; 2019 Jun; 19(1):33. PubMed ID: 31174613
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
